Mercedes Salas-Davalos
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Intestinal-specific Hdac3 deletion increases susceptibility to colitis and small intestinal tumor development in mice fed a high-fat diet.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: October 03, 2023
Correction: ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors Across Tumor Types.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 15, 2023
Author Correction: DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.
Journal: Scientific reports
Published: February 10, 2023
Molecular regulators of lipid metabolism in the intestine - Underestimated therapeutic targets for obesity?
Journal: Biochemical pharmacology
Published: April 27, 2020
An acetate-yielding diet imprints an immune and anti-microbial programme against enteric infection.
Journal: Clinical & translational immunology
Published: January 15, 2020
Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity.
Journal: Nature communications
Published: January 15, 2018
DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.
Journal: Scientific reports
Published: September 04, 2017
Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ-Dependent Manner.
Journal: Cancer immunology research
Published: April 27, 2017
ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 17, 2017
The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.
Journal: The Journal of biological chemistry
Published: June 21, 2015
Last Updated: 09/26/2026